Working… Menu

Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04819269
Recruitment Status : Recruiting
First Posted : March 26, 2021
Last Update Posted : September 22, 2021
Information provided by (Responsible Party):
Sylentis, S.A.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 20, 2022
Estimated Study Completion Date : June 20, 2022